24/7 Patient Assistance: 760-405-8205

Bassam Estfan , MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

  • Bio & Insurance Information

    Dr. Bassam Estfan is a medical oncologist from Cleveland,Ohio and he works at several hospitals in the area, such as Cleveland Clinic.He did his Medical Schooling from Damascus University Faculty of Medicine, and Residency in Internal Medicine from Monmouth Medical Center. The doctor is certified in Medical Oncology & Hospice and Palliative Medicine from American Board of Internal Medicine and has an experience of more than 19 years.

  • Education & Training


    Damascus University Faculty of Medicine

    Medical School


    Monmouth Medical Center



    Cleveland Clinic Foundation


  • Board Certifications

    American Board of Internal Medicine - Hospice & Palliative Medicine

    American Board of Internal Medicine - Oncology

  • Hospital & Practice


    Languages: English/Spanish

    (216) 445-0150

    9500 Euclid Ave Taussig Cancer Institute

    Cleveland, OH 44195

    Read More
  • Publications & Memberships

    Dr. Bassam Estfan has contributed to 3 publications.

    Single-Center Comparison of Overall Survival and Toxicities in Patients with Infiltrative Hepatocellular Carcinoma Treated with Yttrium-90 Radioembolization or Drug-Eluting Embolic Transarterial Chemoembolization.

    McDevitt, J. L.,Alian, A.,Kapoor, B.,Bennett, S.,Gill, A.,Levitin, A.,Sands, M.,Narayanan Menon, K. V.,Aucejo, F. N.,Estfan, B.,Pillai, A. K.,Kalva, S. P.,McLennan, G.; J Vasc Interv Radiol. 1900 Jan 01.

    See more >>

    Symptoms, Quality of Life, and Daily Activities in People With Newly Diagnosed Solid Tumors Presenting to a Medical Oncologist.

    Thomas S, Walsh D, Shrotriya S, Aktas A, Hullihen B, Estfan B, Budd GT, Hjermstad MJ, O'Connor B; Am J Hosp Palliat Care. 2016-05-23.

    See more >>

    Sorafenib in advanced hepatocellular carcinoma: hypertension as a potential surrogate marker for efficacy.

    Estfan, B.,Byrne, M.,Kim, R.; Am. J. Clin. Oncol.. 2013 Aug.

    See more >>